PL365251A1 - Arylowe (lub heteroarylowe) pochodne azolilokarbinolu do leczenia chorób układu oddechowego - Google Patents
Arylowe (lub heteroarylowe) pochodne azolilokarbinolu do leczenia chorób układu oddechowegoInfo
- Publication number
- PL365251A1 PL365251A1 PL02365251A PL36525102A PL365251A1 PL 365251 A1 PL365251 A1 PL 365251A1 PL 02365251 A PL02365251 A PL 02365251A PL 36525102 A PL36525102 A PL 36525102A PL 365251 A1 PL365251 A1 PL 365251A1
- Authority
- PL
- Poland
- Prior art keywords
- heteroaryl
- aryl
- treatment
- derivatives
- azolylcarbynol
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000003851 azoles Chemical class 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200100817A ES2174756B2 (es) | 2001-04-06 | 2001-04-06 | Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias. |
| PCT/ES2002/000136 WO2002080908A1 (es) | 2001-04-06 | 2002-03-21 | Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL365251A1 true PL365251A1 (pl) | 2004-12-27 |
Family
ID=8497368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02365251A PL365251A1 (pl) | 2001-04-06 | 2002-03-21 | Arylowe (lub heteroarylowe) pochodne azolilokarbinolu do leczenia chorób układu oddechowego |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040142994A1 (pl) |
| EP (1) | EP1384476B1 (pl) |
| JP (1) | JP2004531511A (pl) |
| KR (1) | KR20040025913A (pl) |
| CN (1) | CN1230165C (pl) |
| AT (1) | ATE289812T1 (pl) |
| AU (1) | AU2002246151B2 (pl) |
| BR (1) | BR0208807A (pl) |
| CA (1) | CA2443015A1 (pl) |
| DE (1) | DE60203106T2 (pl) |
| DK (1) | DK1384476T3 (pl) |
| ES (2) | ES2174756B2 (pl) |
| HU (1) | HUP0400925A3 (pl) |
| IL (1) | IL158268A0 (pl) |
| MX (1) | MXPA03009125A (pl) |
| NO (1) | NO20034471L (pl) |
| NZ (1) | NZ529303A (pl) |
| PL (1) | PL365251A1 (pl) |
| PT (1) | PT1384476E (pl) |
| RU (1) | RU2294198C2 (pl) |
| WO (1) | WO2002080908A1 (pl) |
| ZA (1) | ZA200308630B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10335566A1 (de) * | 2003-07-31 | 2005-02-24 | Grünenthal GmbH | Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen |
| EP1584335A3 (en) * | 2004-04-05 | 2006-02-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising a carbinol composition and an opioid |
| ES2244326B1 (es) * | 2004-04-05 | 2007-02-16 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de substancias activas. |
| WO2006010627A1 (en) * | 2004-07-30 | 2006-02-02 | Laboratorios Del Dr. Esteve, S.A. | Aryl (or heteroaryl) azolylcarbinols |
| EP1632227A1 (en) * | 2004-09-07 | 2006-03-08 | Laboratorios del Dr. Esteve S.A. | Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction |
| EP1820502A1 (en) * | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| WO2010123999A2 (en) * | 2009-04-21 | 2010-10-28 | Auspex Pharmaceuticals, Inc. | 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2150353B1 (es) * | 1998-04-15 | 2001-07-01 | Esteve Labor Dr | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. |
| ES2137136B1 (es) * | 1998-05-18 | 2000-07-01 | Esteve Labor Dr | Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica. |
| ES2150378B1 (es) * | 1998-08-07 | 2001-07-01 | Esteve Labor Dr | Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p. |
-
2001
- 2001-04-06 ES ES200100817A patent/ES2174756B2/es not_active Expired - Fee Related
-
2002
- 2002-03-21 RU RU2003132456/15A patent/RU2294198C2/ru not_active IP Right Cessation
- 2002-03-21 CA CA002443015A patent/CA2443015A1/en not_active Abandoned
- 2002-03-21 BR BR0208807-0A patent/BR0208807A/pt not_active IP Right Cessation
- 2002-03-21 DE DE60203106T patent/DE60203106T2/de not_active Expired - Fee Related
- 2002-03-21 KR KR10-2003-7013063A patent/KR20040025913A/ko not_active Ceased
- 2002-03-21 EP EP02714232A patent/EP1384476B1/en not_active Expired - Lifetime
- 2002-03-21 AT AT02714232T patent/ATE289812T1/de not_active IP Right Cessation
- 2002-03-21 CN CNB028098943A patent/CN1230165C/zh not_active Expired - Fee Related
- 2002-03-21 NZ NZ529303A patent/NZ529303A/en unknown
- 2002-03-21 WO PCT/ES2002/000136 patent/WO2002080908A1/es not_active Ceased
- 2002-03-21 JP JP2002578947A patent/JP2004531511A/ja not_active Withdrawn
- 2002-03-21 IL IL15826802A patent/IL158268A0/xx unknown
- 2002-03-21 PT PT02714232T patent/PT1384476E/pt unknown
- 2002-03-21 AU AU2002246151A patent/AU2002246151B2/en not_active Ceased
- 2002-03-21 MX MXPA03009125A patent/MXPA03009125A/es active IP Right Grant
- 2002-03-21 US US10/474,232 patent/US20040142994A1/en not_active Abandoned
- 2002-03-21 PL PL02365251A patent/PL365251A1/pl not_active Application Discontinuation
- 2002-03-21 DK DK02714232T patent/DK1384476T3/da active
- 2002-03-21 HU HU0400925A patent/HUP0400925A3/hu unknown
- 2002-03-21 ES ES02714232T patent/ES2236497T3/es not_active Expired - Lifetime
-
2003
- 2003-10-06 NO NO20034471A patent/NO20034471L/no not_active Application Discontinuation
- 2003-11-05 ZA ZA200308630A patent/ZA200308630B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2174756A1 (es) | 2002-11-01 |
| JP2004531511A (ja) | 2004-10-14 |
| PT1384476E (pt) | 2005-05-31 |
| HUP0400925A3 (en) | 2004-10-28 |
| WO2002080908A1 (es) | 2002-10-17 |
| US20040142994A1 (en) | 2004-07-22 |
| KR20040025913A (ko) | 2004-03-26 |
| NO20034471D0 (no) | 2003-10-06 |
| DE60203106T2 (de) | 2006-04-13 |
| CN1535147A (zh) | 2004-10-06 |
| BR0208807A (pt) | 2004-07-13 |
| DE60203106D1 (de) | 2005-04-07 |
| DK1384476T3 (da) | 2005-05-30 |
| RU2003132456A (ru) | 2005-04-10 |
| RU2294198C2 (ru) | 2007-02-27 |
| EP1384476A1 (en) | 2004-01-28 |
| ES2236497T3 (es) | 2005-07-16 |
| IL158268A0 (en) | 2004-05-12 |
| MXPA03009125A (es) | 2005-04-11 |
| ES2174756B2 (es) | 2003-11-16 |
| CN1230165C (zh) | 2005-12-07 |
| ATE289812T1 (de) | 2005-03-15 |
| AU2002246151B2 (en) | 2007-05-31 |
| ZA200308630B (en) | 2004-11-05 |
| NZ529303A (en) | 2005-06-24 |
| CA2443015A1 (en) | 2002-10-17 |
| AU2002246151C1 (en) | 2002-10-21 |
| EP1384476B1 (en) | 2005-03-02 |
| NO20034471L (no) | 2003-12-03 |
| HUP0400925A2 (hu) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LUC00155I1 (pl) | ||
| GEP20104973B (en) | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors | |
| NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
| NO20054852L (no) | GFAT inhibitorer | |
| NO20064577L (no) | Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander | |
| NO20084997L (no) | Pyrazolo[3,4-D]pyrimidinderivater nyttige for a behandle andedrettssykdommer | |
| WO2002055496A8 (en) | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | |
| MY160394A (en) | Novel phenol derivative | |
| CY1110676T1 (el) | ΠΥΡΑΖΟΛΟ[3,4-b]ΠΥΡΙΔΙΝΙΚΕΣ ΕΝΩΣΕΙΣ, ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΦΩΣΦΟΔΙΕΣΤΕΡΑΣΗΣ | |
| ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
| NO20071577L (no) | Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer | |
| HRP20070430T3 (en) | (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity | |
| NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
| WO2009013348A3 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
| WO2005111002A3 (de) | Substituierte cycloalkylderivate zur behandlung von atemswegerkrankungen | |
| MX2010008362A (es) | Derivados de heteroarilamida diazepinopirimidona sustituidos. | |
| MXPA05013904A (es) | Derivados de pirido[2,1-a] isoquinolinas como inhibidores de dipeptidil-peptidasa iv(dpp-iv). | |
| MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
| WO2000068198A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| MXPA04000065A (es) | Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria. | |
| NO20065327L (no) | Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid. | |
| TW200619212A (en) | Morpholine derivatives | |
| IL158268A0 (en) | Azolylcarbinol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases | |
| ATE293961T1 (de) | Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |